Press Releases
WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC (“Turnspire”) effective August 30, 2024. The sale includes custom formulation and contract
WILMINGTON, Del., August 20, 2024 – Ashland Rad-Sure ™ blood irradiation indicators have been approved by the Association for Advancement of Blood and Biotherapies (AABB) Standards-Compliant Product Program designed to offer assurance that blood community products conform to AABB standards.
Planned ribbon cutting event demonstrates company commitment to investment in innovation platforms and local presence Wilmington, Del., Aug. 12, 2024 - Ashland has completed the second expansion of its pharmaceutical injectables manufacturing and R&D lab at the National Science Park in Mullingar,
WILMINGTON, Del., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. The dividend is payable on September 15, 2024, to stockholders of record at the close of business on
Sales of $544 million Net income (including discontinued operations) of $6 million, or $0.12 per diluted share Income from continuing operations of $31 million, or $0.60 per diluted share Adjusted income from continuing operations excluding intangibles amortization expense of $75 million, or $1.49
WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. The company’s live webcast with securities analysts will include an executive summary and detailed
WILMINGTON, Del., June 24, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that Omar Irani will join the company as vice president strategy, mergers and acquisitions, and portfolio management, effective July 22, 2024. Irani will report to Guillermo Novo, chair and chief executive
WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance towards environmental, social and governance (ESG) practices and a more just and equitable society through a relationship with the Fair Wage Network (FWN) to understand living wages for
WILMINGTON, Del., June 04, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that Alessandra Faccin will join the company as senior vice president and general manager, Life Sciences, effective June 10, 2024. Faccin will report to Guillermo Novo, chair and chief executive officer,
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material